Advertisement

Topics

AZ, Bicycle pair up to develop bicyclic peptides

05:35 EST 2 Dec 2016 | PharmaTimes

AstraZeneca and Bicycle Therapeutics have entered into a deal to develop bicyclic peptides that could net the latter firm more than $1 billion if all pre-specified targets are met.

Original Article: AZ, Bicycle pair up to develop bicyclic peptides

NEXT ARTICLE

More From BioPortfolio on "AZ, Bicycle pair up to develop bicyclic peptides"

Quick Search
Advertisement
 

Relevant Topic

AstraZeneca
AstraZeneca is ranked 6th in the world, based on a pharmaceutical annual sales, which were valued at $32,800 million in 2009.  it is a global company, working in more than 100 countries, and employing 62,000 people, around a sixth of which are dedic...